Search Results 341-350 of 11877 for Lupus

  1. Alexander R. Shusko, Jr., M.D. - Doctors and Medical Staff - Mayo Clinic

    Alexander Shusko, M.D., is an Ophthalmologist with expertise in ocular inflammatory disorders of the eye. Dr. Shusko completed his medical training at ...

  2. A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab Monotherapy in Participants With Select B-Cell Malignancies (MorningSun) - Mayo Clinic

    myositis, autoimmune hepatitis, systemic lupus erythematosus, rheumatoid arthritis, inflammatory bowel disease, vascular thrombosis associated with anti ...

  3. Adalimumab-adaz (subcutaneous route) - Mayo Clinic

    Some people who have used this medicine developed lupus-like symptoms during treatment and got better after the medicine was stopped. Check with your doctor ...

  4. Publications - Megan M. Sullivan, M.D. - Mayo Clinic

    Clinical Images: Dacryoadenitis as the herald symptom for systemic lupus erythematosus. ACR Open Rheumatol. 2023 Sep; 5(9):436. Epub 2023 Jun 06. View ...

  5. Chemotherapy - Mayo Clinic

    Immune system disorders. Lower doses of chemotherapy drugs can help control an overactive immune system in certain diseases, such as lupus and rheumatoid ...

  6. Publications - Olayemi Sokumbi, M.D. - Mayo Clinic

    Collagen Vascular Diseases: A Review of Cutaneous and Systemic Lupus Erythematosus, Dermatomyositis, and Distinguishing Features in Skin of Color.

  7. Infliximab-axxq (intravenous route) - Side effects & uses - Mayo Clinic

    This medicine may increase your or your child's risk of having a lupus-like syndrome or a liver disease called autoimmune hepatitis. Check with your doctor ...

  8. Autoimmune pancreatitis - Symptoms and causes - Mayo Clinic

    Autoimmune pancreatitis is a relatively uncommon disease of the pancreas that may be mistaken for pancreatic cancer.

  9. Methsuximide (oral route) - Side effects & dosage - Mayo Clinic

    Systemic lupus erythematosus (immune system disease)—Use with caution. May make these conditions worse. Infection—May reduce your body's ability to fight an ...

  10. A Study to Evaluate The Effectiveness and Safety of Abrocitinib, with or without Topical Medications, in Subjects Aged 12 Years and Older with Moderate-to-Severe Atopic Dermatitis - Mayo Clinic

    Currently have active forms of other inflammatory skin diseases; i.e., not AD or have evidence of skin conditions (eg, psoriasis, seborrheic dermatitis, Lupus) ...